Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1992 3
1993 18
1994 8
1995 14
1996 7
1997 7
1998 8
1999 5
2000 4
2001 2
2002 7
2003 14
2004 59
2005 67
2006 62
2007 50
2008 29
2009 39
2010 23
2011 18
2012 18
2013 9
2014 1
2016 2
2017 4
2018 1
2019 2
2020 10
Text availability
Article attribute
Article type
Publication date

Search Results

460 results
Results by year
Filters applied: . Clear all
Page 1
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor.
Hoffmann M, Kleine-Weber H, Schroeder S, Krüger N, Herrler T, Erichsen S, Schiergens TS, Herrler G, Wu NH, Nitsche A, Müller MA, Drosten C, Pöhlmann S. Hoffmann M, et al. Cell. 2020 Apr 16;181(2):271-280.e8. doi: 10.1016/j.cell.2020.02.052. Epub 2020 Mar 5. Cell. 2020. PMID: 32142651 Free PMC article.
Optimization of the Production Process and Characterization of the Yeast-Expressed SARS-CoV Recombinant Receptor-Binding Domain (RBD219-N1), a SARS Vaccine Candidate.
Chen WH, Chag SM, Poongavanam MV, Biter AB, Ewere EA, Rezende W, Seid CA, Hudspeth EM, Pollet J, McAtee CP, Strych U, Bottazzi ME, Hotez PJ. Chen WH, et al. Version 2. J Pharm Sci. 2017 Aug;106(8):1961-1970. doi: 10.1016/j.xphs.2017.04.037. Epub 2017 Apr 26. J Pharm Sci. 2017. PMID: 28456726 Free PMC article.
The biological characteristics of SARS-CoV-2 spike protein Pro330-Leu650.
Su QD, Yi Y, Zou YN, Jia ZY, Qiu F, Wang F, Yin WJ, Zhou WT, Zhang S, Yu PC, Bi SL, Shen LP, Wu GZ. Su QD, et al. Vaccine. 2020 Jul 6;38(32):5071-5075. doi: 10.1016/j.vaccine.2020.04.070. Epub 2020 Apr 30. Vaccine. 2020. PMID: 32513514 Free PMC article.
460 results
Jump to page
Feedback